Radiopharm Theranostics Limited American Depositary Shares

RADX XNAS

Market Cap

28M

Short interest (Jul 15)

0.8%

Net Short (Jul 27 ): -0.2%

Borrow Fee

33.85%

↓ 1.8%

Available Shares

20K

↓ 52.9%

Price Chart

Company Overview

Radiopharm Theranostics Ltd is an Australian-based clinical-stage radiotherapeutics company targeting cancer. The company has a pipeline of approximately four licensed platform technologies, with diagnostic and therapeutic applications at both the pre-clinical and clinical stages of development. The company is engaged in research, development, and commercialization of health technologies.

Company Info

Exchange: NASDAQ
CIK: 0001949257
Asset Type: ADRC

Market Data

Market Cap: $27,985,235
Employees: 14
Status: Active

Short Interest

Current Borrow Fee 33.85%
Range: 33.85% - 33.85%
Available Shares 20K
Range: 15K - 35K

Recent Changes

Fee Change: ↑ 11.9%
Available Change: ↓ 53.3%

Quick Actions

View Dilution Chart
Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam Unsubscribe anytime